医用大麻市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00022901
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 181
Buy Now

[研究报告]2021年医用大麻市场规模为117.065亿美元,预计到2028年将达到400.2759亿美元;预计2022年至2028年复合年增长率为19.2%。

分析师观点

医用大麻的种植和使用已在美国已合法化。在美国,截至2022年2月,大麻已在37个州和哥伦比亚特区实现医疗用途合法化。加拿大于2018年通过了《大麻法案》,对控制大麻的生产、分销、销售和拥有制定了严格的规定全国各地。墨西哥、卢森堡、莱索托和其他几个国家最近已将大麻的医疗用途合法化。乌拉圭于 2012 年成为第一个将娱乐性大麻合法化的国家。另一方面,巴西于 2014 年授权使用医用大麻,并于 2016 年允许进口基于 CBD 油的药物、基于 THC 的产品和大麻花。 2017年,秘鲁根据立法授权大麻及其衍生物的药用和治疗用途。

尽管大麻的使用已在许多国家合法化,但大麻的种植和生产主要限于发展中国家。 2019年9月,牙买加商业、农业和渔业部宣布与哈佛国际植物医学和医用大麻研究所(HIPI)合作,开展大麻药理益处的研究。牙买加还打算利用这种伙伴关系来发展其国家大麻产业。此外,世界卫生组织 (WHO) 报告称,全球约 80% 的人口将大麻或大麻用于医疗目的。因此,发展中国家对医用大麻的接受度、种植和生产的不断增加,极大地促进了医用大麻市场的增长。

市场概览

医用大麻通过使用大麻植物或其成分来治疗疾病或不适。它与休闲大麻是同一产品,但用于医疗目的。医用大麻继续对医疗保健行业产生重大影响,特别是在传统药物不完全适用的情况下。从本质上讲,医用大麻只是一种典型的大麻植物,经过加工以获得合成产品所需的大麻素的基本成分。促进该市场增长的关键因素之一是医用大麻产品的批准不断增加以及大麻药用特性的接受度不断提高。然而,大麻作为街头毒品的非法使用以及对大麻的误解也阻碍了市场的增长,限制了其在医疗领域的潜在应用。

战略见解

市场驱动力

医用大麻产品的批准增加,推动医用大麻市场增长

大麻的药用潜力吸引了各种研究人员和公司在医疗应用中使用大麻。例如,四氢大麻酚(THC)主要用于生产医药产品。美国食品和药物管理局 (FDA) 已批准基于 THC 的医药产品,例如 Cesamet,其活性成分为 naboline,是一种与 THC 结构相似的合成衍生产品。 Cesamet 用于治疗接受化疗的患者的恶心。当其他药物无法控制恶心和呕吐时,通常会开出 Cesamet。 FDA 还批准 Marinol 和 Syndros 在美国用于治疗用途。 Marinol 和 Syndros 含有活性成分屈大麻酚——一种合成的 9-THC,被认为是大麻的精神活性成分。 Marinol 和 Syndros 药物用于刺激患有消耗综合症的患者的食欲,消耗综合症是艾滋病的适应症之一。同样,各种基于大麻的产品已获得批准或正在进行临床试验。例如,nabiximols (Sativex) 是一种在加拿大批准商业化的药物。 Nabiximols 是一种大麻提取物,用于治疗与多发性硬化症相关的痉挛和神经性疼痛。它由 THC 和其他大麻二酚 (CBD) 组合配制而成。 2020年2月,加拿大公司CanaQuest Medical Corp向加拿大卫生部申请批准Mentabinol的生产和商业化。 Mentabinol 是一种基于 THC 的产品,其批准申请已根据《大麻法》提交。 FDA 对上述大麻产品的批准增加正在推动医用大麻市场的增长。

细分分析基于产品见解

根据产品,医用大麻市场分为干燥形式和提取物形式。提取物细分市场在 2021 年占据最大份额,预计在预测期内医用大麻市场的复合年增长率最高。提取物形式细分市场的增长归因于多种因素,包括医疗应用中对液体提取物的需求不断增加、人们对提取物相对于干大麻的益处的认识不断提高,以及随着天然保健品消费的健康和保健趋势的不断增长.

大麻提取物是一种特定类型的大麻浓缩物。该提取物是从大麻植物中获得的,经过加工,通过去除多余的植物材料和其他杂质来保留植物最需要和最想要的化合物。与天然大麻花相比,大麻浓缩物含有更高比例的萜烯和大麻素。此外,大麻浓缩物还有助于提高花的效力。由于多种原因,人们可以自行食用大麻浓缩物,无需进一步加工。用于生产大麻浓缩物的一些工艺包括干加工、干冰加工、水基加工、压力/热处理以及使用易燃或不易燃溶剂。一旦生产出来,浓缩物可能看起来像液体蜡、软固体或硬固体。

基于应用的见解

基于应用程序中,医用大麻市场分为疼痛管理、图雷特氏症、阿尔茨海默氏病、偏头痛、抑郁和焦虑、多发性硬化症、癌症等。疼痛管理细分市场在 2021 年占据最大的医用大麻市场份额,预计在预测期内复合年增长率最高。

基于分销渠道的见解

从分销渠道来看,医用大麻市场分为零售药店、电商等。 2021 年,零售药房领域占据了最大的医用大麻市场份额。然而,预计电子商务领域在预测期内的复合年增长率最高。

医疗大麻市场,按产品分类2021年和2028年

区域分析

北美在2021年医用大麻市场中占据最大的市场份额,预计在预测期间将保持其市场地位时期。推动北美市场增长的因素包括大麻在医疗领域的日益增长的应用、与大麻益处相关的研究活动以及发达的医疗基础设施可能在预测期内为市场参与者提供更广泛的增长机会。此外,产品的推出也推动了北美医用大麻市场的增长。在北美,美国的医用大麻市场份额最高。不断增长的老年人口中慢性疾病的发病率不断上升,以及主要市场参与者的不断扩大,推动了该国医用大麻市场的发展。此外,美国大麻合法化的不断推进以及政府对加强医用大麻研究的支持力度不断加大,也为到 2028 年医用大麻市场的参与者提供了一个有吸引力的环境。

 

Aphria , Inc . 、 Canopy Growth Corporation 、 CanaQuest Medical Corporation 、 GW Pharmaceuticals 、 Organigram Holdings Inc . 、 VIVO Cannabis Inc . 、 Panaxia Pharmaceutical Industries Ltd . 、 Phoena Holdings Inc . 、 Emerald Health Therapeutics Inc . 和 MARICANN INC 均在其中全球医用大麻市场增长的领先企业。对其他几个重要的市场参与者进行了分析,以全面了解市场及其生态系统。该报告提供了详细的市场洞察,帮助主要参与者制定市场增长战略。以下是一些进展:

2021年11月,VIVO Cannabis Inc.在其Beacon下推出了最新的医用大麻产品配方:高剂量大麻二酚(CBD)油医疗品牌。 Beacon Medical 油产品的整个系列均采用非转基因食品级中链甘油三酯 (MCT) 基础油配制而成,最终产品无嗅无味。 VIVO 同时启动了儿科同情护理计划,以支持需要医用大麻来治疗各种儿科疾病的护理人员和家庭。

2020 年 11 月,Panaxia Global 以色列子公司 Panaxia Labs Israel Ltd. (Panaxia Israel) 完成了欧洲最大且增长最快的大麻市场德国卫生当局的注册程序并获得了最终监管批准,用于营销和分销一系列医用大麻优质产品。该产品将以 Naxiva-Panaxol 品牌在德国上市。

2020 年 9 月,Emerald Health Therapeutics, Inc. 和 STENOCARE A/S 获得特别批准瑞典药品管理局向已通过医生申请使用此类产品进行治疗的瑞典患者提供医用大麻油。根据 2019 年 11 月签署的协议,Emerald 向丹麦和瑞典等其他市场供应 STENOCARE 医用大麻产品。这些公司目前正在与瑞典当局一起处理所需的信息,以便开始在瑞典进口和分销。

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the Medical Marijuana market?

Medical marijuana is a term for derivatives of the Cannabis sativa plant that are used to ease symptoms caused by certain medical conditions. Medical marijuana is also known as medical cannabis. Cannabis sativa contains many active compounds. The best known are delta-9 tetrahydrocannabinol (THC) and cannabidiol (CBD). THC is the primary ingredient in marijuana. Medical marijuana uses the marijuana plant or chemicals in it to treat diseases or conditions. It's basically the same product as recreational marijuana, but it's taken for medical purposes.

Who are the major players in the medical marijuana market?

The medical marijuana market majorly consists of the players such as Aphria, Inc.; Canopy Growth Corporation; CanaQuest Medical Corporation; GW Pharmaceuticals; Organigram Holdings Inc.; VIVO Cannabis Inc.; Panaxia Pharmaceutical Industries Ltd.; Phoena Holdings Inc.; Emerald Health Therapeutics Inc.; and MARICANN INC.

What are the driving factors for the medical marijuana market across the country?

The factors that are driving and restraining factors that will affect the medical marijuana market in the coming years. Factors such as increasing approvals of medical marijuana products and rising acceptance of medicinal use of marijuana in America. However, the illegal use of cannabis as a street drug and misconceptions regarding marijuana is likely to have a negative impact on the growth of the market in the coming years.

Which segment is dominating the medical marijuana market?

The global medical marijuana market based on product is dried form and extract form. The extract form segment is likely to hold the largest share of the market in 2022. Moreover, the segment is anticipated to register the highest CAGR in the market during the forecast period.

The List of Companies - Medical Marijuana Market

  1. Aphria, Inc.
  2. Canopy Growth Corporation
  3. CanaQuest Medical Corporation
  4. GW Pharmaceuticals
  5. Organigram Holdings Inc.
  6. VIVO Cannabis Inc
  7. Panaxia Pharmaceutical Industries Ltd.
  8. Phoena Holdings Inc.
  9. Emerald Health Therapeutics Inc.
  10. MARICANN INC.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports